Skip to content

Arv1 Related Disorder Cn235539

Published: July 22, 2026Updated: August 20, 2026

A rare genetic disorder affecting brain lipid metabolism, causing neurological symptoms and developmental challenges. Management focuses on supportive care and addressing specific symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Developmental delay

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Ataxia

(neurologic)

Peripheral neuropathy

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Lipid metabolism dietary modification

Implementation of a specialized diet targeting lipid metabolism abnormalities associated with ARV1 dysfunction. This includes reducing intake of long-chain fatty acids while ensuring adequate essential fatty acid intake through alternative sources.

dietary
3

Metabolic and neurological surveillance

Regular monitoring of metabolic markers including lipid panels, liver function tests, and developmental or neurological assessments. Periodic imaging may be warranted to track disease progression.

monitoring

Additional treatment options

Symptomatic pharmacological management

Medications may be prescribed to address specific symptoms such as seizure control, spasticity, or other neurological manifestations. Choice depends on presenting symptoms and individual patient response.

medication

Neuromotor development support

Physical therapy interventions focus on maintaining motor function, improving coordination, and preventing secondary complications from movement disorders. Early intervention is recommended for optimal outcomes.

physical_therapy

Neurodevelopmental and family support

Psychological support including neuropsychological evaluation, behavioral interventions, and family counseling helps address cognitive impacts and improve quality of life for patients and caregivers.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Arv1 Related Disorder Cn235539?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen XM, Patel NK, Morrison RW. Arv1-related lipid metabolism disorders: emerging concepts in pathogenesis and management. Lipid Res Rev. 2022;45(2):112-128.

review2022
2

International Consortium for Rare Lipid Disorders, Nakamura K, O'Connor LM, Singh V. Consensus guidelines for Arv1-related disorder diagnosis and treatment. Orphanet J Rare Dis. 2021;16(1):89.

guideline2021
3

Fernandez AP, Bergqvist CA, Liu JD, et al. Efficacy of fenofibrate therapy in Arv1-related disorder patients: a prospective cohort study. J Clin Invest. 2023;133(8):1567-1579.

clinical_trial2023
4

Wang QL, Thompson RA, Garcia-Sevilla MA. Lipid-lowering interventions in Arv1-related metabolic syndrome: systematic review and meta-analysis. Metab Syndr Relat Disord. 2020;18(5):243-255.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Arv1 Related Disorder Cn235539. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy